Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice M Turner

Showing results (1-10 of 152) with videos related to

Pageof 16
Sort By:
Plos Genetics|August 31, 2013
Fifty years on: GWAS confirms the role of a rare variant in lung diseaseAlice M Turner
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 18, 2013
Alpha-1 antitrypsin deficiency: new developments in augmentation and other therapiesAlice M Turner
Biomedicines|February 25, 2022
Chronic Obstructive Pulmonary Disease: The Present and FutureAditya Krishnan, Alice M Turner
Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine|May 24, 2013
Pharmacotherapies for COPDStan Ejiofor, Alice M Turner
Expert Opinion on Investigational Drugs|September 26, 2019
Experimental and investigational drugs for the treatment of alpha-1 antitrypsin deficiencyAnita Pye, Alice M Turner
Faculty Reviews|March 4, 2021
Alpha-1 antitrypsin deficiency: an update on clinical aspects of diagnosis and managementGabriela Santos, Alice M Turner
The European Respiratory Journal|November 2, 2019
Identifying the at risk smokers: who goes on to get COPD?Arina Madan, Alice M Turner
The European Respiratory Journal|October 16, 2020
Modernising case finding for α<sub>1</sub>-antitrypsin deficiency by DNA sequencing of COPD patientsMark Quinn, Alice M Turner
Multidisciplinary Respiratory Medicine|December 3, 2015
The role of iron in pulmonary pathologyHeena Khiroya, Alice M Turner
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|July 23, 2020
Why is Disease Penetration so Variable in Alpha-1 Antitrypsin Deficiency? The Contribution of Environmental FactorsMadhu Rangaraju, Alice M Turner
Pageof 16

Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
Plos Genetics|August 31, 2013
Fifty years on: GWAS confirms the role of a rare variant in lung diseaseAlice M Turner
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 18, 2013
Alpha-1 antitrypsin deficiency: new developments in augmentation and other therapiesAlice M Turner
Biomedicines|February 25, 2022
Chronic Obstructive Pulmonary Disease: The Present and FutureAditya Krishnan, Alice M Turner
Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine|May 24, 2013
Pharmacotherapies for COPDStan Ejiofor, Alice M Turner
Expert Opinion on Investigational Drugs|September 26, 2019
Experimental and investigational drugs for the treatment of alpha-1 antitrypsin deficiencyAnita Pye, Alice M Turner
Faculty Reviews|March 4, 2021
Alpha-1 antitrypsin deficiency: an update on clinical aspects of diagnosis and managementGabriela Santos, Alice M Turner
The European Respiratory Journal|November 2, 2019
Identifying the at risk smokers: who goes on to get COPD?Arina Madan, Alice M Turner
The European Respiratory Journal|October 16, 2020
Modernising case finding for α<sub>1</sub>-antitrypsin deficiency by DNA sequencing of COPD patientsMark Quinn, Alice M Turner
Multidisciplinary Respiratory Medicine|December 3, 2015
The role of iron in pulmonary pathologyHeena Khiroya, Alice M Turner
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|July 23, 2020
Why is Disease Penetration so Variable in Alpha-1 Antitrypsin Deficiency? The Contribution of Environmental FactorsMadhu Rangaraju, Alice M Turner
Pageof 16